4082
SA:MRNA
مرنة للتمويل
- Stock
Last Close
11.34
24/11 12:17
Market Cap
767.14M
Beta: -
Volume Today
254.82K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|
average inventory | 37.26M - | ||||
average payables | 4.87M - | 2.22M 54.47% | |||
average receivables | 1.05B - | ||||
book value per share | 6.51 - | 5.12 21.27% | 13.65 - | ||
capex per share | -0.06 - | -0.02 68.60% | -0.17 - | ||
capex to depreciation | -0.83 - | -0.33 59.88% | -1.19 258.74% | -0.89 25.67% | |
capex to operating cash flow | 0.01 - | 0.02 66.46% | 0.13 505.62% | 0.16 25.90% | |
capex to revenue | -0.03 - | -0.01 62.26% | -0.05 441.78% | -0.06 8.35% | |
cash per share | 1.84 - | 0.61 66.74% | 1.76 - | ||
days of inventory on hand | |||||
days payables outstanding | 39.48 - | 22.91 41.98% | |||
days sales outstanding | 2.60K - | 2.11K - | |||
debt to assets | 0.65 - | 0.63 2.85% | 0.51 18.85% | 0.33 34.22% | |
debt to equity | 1.94 - | 1.79 8.20% | 1.11 37.61% | 0.54 51.83% | |
dividend yield | 0.05 - | ||||
earnings yield | 0.05 - | 0.04 15.69% | 0.05 - | ||
enterprise value | 1.31B - | 1.65B 26.58% | 552.74M 66.57% | 1.12B 102.16% | |
enterprise value over ebitda | 29.68 - | 16.61 44.02% | 6.14 63.01% | 21.54 250.58% | |
ev to operating cash flow | -5.75 - | -27.03 369.77% | -8.39 68.95% | -16.72 99.22% | |
ev to sales | 11.62 - | 12.37 6.50% | 3.44 72.22% | 5.89 71.45% | |
free cash flow per share | -4.60 - | -0.87 80.98% | -1.26 - | ||
free cash flow yield | -0.31 - | -0.06 80.98% | -0.10 - | ||
graham net net | 0.75 - | -8.86 1,277.11% | 7.03 - | ||
graham number | 9.97 - | 8.12 18.53% | 13.54 - | ||
income quality | -6.69 - | -1.29 80.74% | -1.21 6.18% | -1.82 50.98% | |
intangibles to total assets | 0 - | 0.00 Infinity% | 0.04 833.48% | 0 100% | |
interest coverage | 53.58 - | ||||
interest debt per share | 12.67 - | 9.14 27.82% | 7.32 - | ||
inventory turnover | |||||
invested capital | 1.94 - | 1.79 8.20% | 1.11 37.61% | 0.54 51.83% | |
market cap | 730M - | 1.04B 42.86% | 759.27M - | ||
net current asset value | -655.43M - | 352.48M 153.78% | 504.32M 43.08% | -500.35M 199.21% | |
net debt to ebitda | 13.09 - | 6.13 53.14% | 6.14 0.18% | 6.90 12.36% | |
net income per share | 0.68 - | 0.57 15.69% | 0.60 - | ||
operating cash flow per share | -4.54 - | -0.86 81.14% | -1.09 - | ||
payables turnover | 9.24 - | 15.94 72.37% | |||
receivables turnover | 0.14 - | 0.17 - | |||
research and ddevelopement to revenue | |||||
return on tangible assets | 0.03 - | 0.04 13.84% | 0.04 2.66% | 0.03 28.86% | |
revenue per share | 2.25 - | 1.87 16.80% | 3.09 - | ||
roe | 0.10 - | 0.11 7.10% | 0.08 27.96% | 0.04 45.65% | |
roic | 0.04 - | 0.08 124.06% | 0.06 28.39% | 0.02 58.79% | |
sales general and administrative to revenue | 0.07 - | 0.10 41.26% | |||
shareholders equity per share | 6.51 - | 5.12 21.27% | 13.65 - | ||
stock based compensation to revenue | |||||
tangible asset value | 325.33M - | 361.24M 11.04% | 518.61M 43.56% | 842.23M 62.40% | |
tangible book value per share | 6.51 - | 5.06 22.27% | 13.73 - | ||
working capital | -287.24M - | 1.02B 454.03% | 1.14B 12.27% | -237.54M 120.81% |
All numbers in (except ratios and percentages)